dTBP2 attenuates severe airway inflammation by blocking inflammatory cellular network mediated by dTCTP
Dimeric translationally controlled tumor protein (dTCTP), also known as histamine-releasing factor, amplifies allergic responses and its production has been shown to increase in inflammatory diseases such as allergic asthma. Despite the critical role of dTCTP in allergic inflammation, little is know...
Main Authors: | Hyunsoo Cho, Hyo Kyeong Kim, Areum Oh, Mi Gyeong Jeong, Jiseo Song, Kyunglim Lee, Eun Sook Hwang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332221011008 |
Similar Items
-
PEGylation improves the therapeutic potential of dimerized translationally controlled tumor protein blocking peptide in ovalbumin-induced mouse model of airway inflammation
by: Hyeran Seo, et al.
Published: (2022-12-01) -
Dimerized Translationally Controlled Tumor Protein-Binding Peptide Ameliorates Atopic Dermatitis in NC/Nga Mice
by: Xing-Hai Jin, et al.
Published: (2017-01-01) -
Dimeric translationally controlled tumor protein–binding peptide 2 attenuates imiquimod-induced psoriatic inflammation through induction of regulatory T cells
by: Hyunsoo Cho, et al.
Published: (2022-08-01) -
Role of Translationally Controlled Tumor Protein (TCTP) in the Development of Hypertension and Related Diseases in Mouse Models
by: Jeehye Maeng, et al.
Published: (2022-10-01) -
Dysregulation of TCTP in Biological Processes and Diseases
by: Ulrich-Axel Bommer, et al.
Published: (2020-07-01)